-
"Ruxolitinib"
Lebitso la API Pontsho Moqapi Letsatsi la Phello ea Patent(US) "Ruxolitinib" Myelofibrosis Novartis La 6 Phupu 2024 -
Crisaborole
Lebitso la API Pontsho Moqapi Letsatsi la Phello ea Patent(US) Crisaborole Dermatitis ea Atopic le Eczema Pfizer La 11 Phuptjane 2026 -
Vericiguat
Lebitso la API Pontsho Moqapi Letsatsi la Phello ea Patent(US) Vericiguat Ho hloleha ha pelo Bayer le MSD Mots'eanong.La 24, 2031 -
Abrocitinib
Lebitso la API Pontsho Moqapi Letsatsi la Phello ea Patent(US) Abrocitinib Dermatitis ea Atopic Pfizer Hlakola.11, 2034 -
Rimegepant
Lebitso la API Pontsho Moqapi Letsatsi la Phello ea Patent(US) Rimegepant Hlooho ea Migraine Biohaven Hlakola 22, 2031 -
Elagolix 834153-87-6
Lebitso la API Pontsho Tlhaloso US DMF EU DMF CEP ElagolixCAS:834153-87-6 Endometriosis Ka Ntlong -
Relugolix 737789-87-6
Lebitso la API Pontsho Tlhaloso US DMF EU DMF CEP Ribociclib CAS: 737789-87-6 Antineoplastic Ka Ntlong -
Venetoclax 1257044-40-8
Lebitso la API Pontsho Moqapi Letsatsi la Phello ea Patent(US) Venetoclax 1257044-40-8 CLL Abbvie Phup.27,2031 -
Velpatasvir(PVP)
Lebitso la API Pontsho Tlhaloso US DMF EU DMF CEP Velpatasvir(PVP) HCV Ka Ntlong √ -
Thalidomide
Lebitso la API Pontsho Tlhaloso US DMF EU DMF CEP Thalidomide Moriana oa Oncology USP/EP -
Ticagrelor
Lebitso la API Pontsho Tlhaloso US DMF EU DMF CEP Ticagrelor Anticoagulant Ka Ntlong 28984 √